A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis
SUMMARY Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder that results in the death of motor neurons in the brain and spinal cord. The disorder generally strikes in mid-life, relentlessly leading to paralysis and death, typically 3-5 years after diagnosis. No effective...
Saved in:
Main Authors: | Abraham Acevedo-Arozena (Author), Bernadett Kalmar (Author), Shafa Essa (Author), Thomas Ricketts (Author), Peter Joyce (Author), Rosie Kent (Author), Claire Rowe (Author), Andy Parker (Author), Anna Gray (Author), Majid Hafezparast (Author), Julian R. Thorpe (Author), Linda Greensmith (Author), Elizabeth M. C. Fisher (Author) |
---|---|
Format: | Book |
Published: |
The Company of Biologists,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroprotective Effects of Shenqi Fuzheng Injection in a Transgenic SOD1-G93A Mouse Model of Amyotrophic Lateral Sclerosis
by: Kazuo Sugimoto, et al.
Published: (2021) -
Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis
by: Francesca De Giorgio, et al.
Published: (2019) -
Gamisoyo-San Ameliorates Neuroinflammation in the Spinal Cord of hSOD1G93A Transgenic Mice
by: MuDan Cai, et al.
Published: (2018) -
The transcription factor Nurr1 is upregulated in amyotrophic lateral sclerosis patients and SOD1-G93A mice
by: Valeria Valsecchi, et al.
Published: (2020) -
Caudal-Rostral Progression of Alpha Motoneuron Degeneration in the SOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis
by: Alastair J. Kirby, et al.
Published: (2022)